(3Z)-1H-Indole-2,3-dione-3-{[3-(3-chlorophenyl)-4-oxo-3,4-dihydroquinazolin-2-yl]hydrazone}

ID: ALA4279998

Chembl Id: CHEMBL4279998

PubChem CID: 145982146

Max Phase: Preclinical

Molecular Formula: C22H14ClN5O2

Molecular Weight: 415.84

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1Nc2ccccc2/C1=N/Nc1nc2ccccc2c(=O)n1-c1cccc(Cl)c1

Standard InChI:  InChI=1S/C22H14ClN5O2/c23-13-6-5-7-14(12-13)28-21(30)16-9-2-4-11-18(16)25-22(28)27-26-19-15-8-1-3-10-17(15)24-20(19)29/h1-12H,(H,25,27)(H,24,26,29)

Standard InChI Key:  FMSFDQOAINSAON-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4279998

    ---

Associated Targets(Human)

MIA PaCa-2 (5949 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cckbr Cholecystokinin B receptor (792 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cckbr Cholecystokinin B receptor (729 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 415.84Molecular Weight (Monoisotopic): 415.0836AlogP: 3.81#Rotatable Bonds: 3
Polar Surface Area: 88.38Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 9.93CX Basic pKa: 2.49CX LogP: 4.45CX LogD: 4.45
Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.50Np Likeness Score: -1.35

References

1. Kumari S, Chowdhury J, Sikka M, Verma P, Jha P, Mishra AK, Saluja D, Chopra M..  (2017)  Identification of potent cholecystokinin-B receptor antagonists: synthesis, molecular modeling and anti-cancer activity against pancreatic cancer cells.,  (7): [PMID:30108868] [10.1039/C7MD00171A]

Source